Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
Inovio Pharmaceuticals
INO
$76.1M
| $163K | ﹤0.01% |
1,733
+1,504
| +657% | +$129K |
|
|
HAPN
4477
PUT
Happen Inc
HAPN
$2.24B
| $163K | ﹤0.01% |
5,900
+440
| +8% | +$12.5K |
|
|
ARRS
4478
CALL
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $163K | ﹤0.01% |
5,800
-12,600
| -68% | -$346K |
|
|
UN
4479
DELISTED
Unilever NV New York Registry Shares
UN
| $163K | ﹤0.01% |
2,956
-1,648
| -36% | -$89K |
|
4480
PUT
Core Laboratories
CLB
$561M
| $162K | ﹤0.01% |
1,600
-700
| -30% | -$75.5K |
|
4481
CALL
Canadian Imperial Bank of Commerce
CM
$109B
| $162K | ﹤0.01% |
4,000
+600
| +18% | +$24.2K |
|
4482
CALL
Vail Resorts
MTN
$5.21B
| $162K | ﹤0.01% |
800
+400
| +100% | +$80.6K |
|
|
SPR
4483
CALL
DELISTED
Spirit AeroSystems
SPR
| $162K | ﹤0.01% |
+2,800
| New | +$157K |
|
4484
PUT
Kennametal
KMT
$2.41B
| $161K | ﹤0.01% |
+4,300
| New | +$168K |
|
4485
CALL
Nokia
NOK
$51B
| $161K | ﹤0.01% |
26,200
+4,500
| +21% | +$27K |
|
|
TUES
4486
DELISTED
Tuesday Morning Corp
TUES
| $161K | ﹤0.01% |
84,990
+78,121
| +1,137% | +$191K |
|
|
HF
4487
DELISTED
HFF Inc.
HF
| $161K | ﹤0.01% |
4,614
-502
| -10% | -$15.5K |
|
4488
CareTrust REIT
CTRE
$9.55B
| $160K | ﹤0.01% |
8,624
+6,867
| +391% | +$124K |
|
4489
iShares MSCI Malaysia ETF
EWM
$330M
| $160K | ﹤0.01% |
5,051
| – | – |
|
4490
HealthStream
HSTM
$859M
| $160K | ﹤0.01% |
6,102
+5,626
| +1,182% | +$155K |
|
4491
John B. Sanfilippo & Son
JBSS
$965M
| $160K | ﹤0.01% |
2,531
+364
| +17% | +$24.3K |
|
4492
Novartis
NVS
$298B
| $160K | ﹤0.01% |
2,142
-9,176
| -81% | -$650K |
|
4493
abrdn Physical Gold Shares ETF
SGOL
$7.49B
| $160K | ﹤0.01% |
13,300
| – | – |
|
4494
PUT
SLM Corp
SLM
$5.14B
| $160K | ﹤0.01% |
13,900
-5,700
| -29% | -$64.9K |
|
|
AUY
4495
CALL
DELISTED
Yamana Gold, Inc.
AUY
| $160K | ﹤0.01% |
65,800
-34,600
| -34% | -$93.4K |
|
|
VRTU
4496
DELISTED
Virtusa Corporation
VRTU
| $160K | ﹤0.01% |
5,442
+1,949
| +56% | +$57.3K |
|
|
HZNP
4497
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $160K | ﹤0.01% |
13,500
-1,222,300
| -99% | -$15.2M |
|
4498
CALL
DTE Energy
DTE
$28.5B
| $159K | ﹤0.01% |
1,763
+1,528
| +650% | +$138K |
|
4499
Otter Tail
OTTR
$3.88B
| $159K | ﹤0.01% |
4,017
-5,848
| -59% | -$230K |
|
4500
CALL
Teradata
TDC
$2.58B
| $159K | ﹤0.01% |
5,400
-700
| -11% | -$20.5K |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.